58,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

From Viruses to Victory: Recent Advances in Influenza Therapy is an expansive collection of scientific journal articles that explore the latest developments and strategies in combating influenza. This anthology covers a wide spectrum of topics, from pediatric antiviral treatments to the use of innovative drug combinations, shedding light on the efficacy and economic viability of different therapies. It begins with an examination of antiviral and glucocorticoid therapies in children, revealing that symptomatic treatment can sometimes outperform aggressive pharmaceutical interventions. The focus…mehr

Produktbeschreibung
From Viruses to Victory: Recent Advances in Influenza Therapy is an expansive collection of scientific journal articles that explore the latest developments and strategies in combating influenza. This anthology covers a wide spectrum of topics, from pediatric antiviral treatments to the use of innovative drug combinations, shedding light on the efficacy and economic viability of different therapies. It begins with an examination of antiviral and glucocorticoid therapies in children, revealing that symptomatic treatment can sometimes outperform aggressive pharmaceutical interventions. The focus then shifts to adult treatment trends in Canada post-H1N1 pandemic and provides empirical evidence on the fluctuating use of antiviral drugs. Groundbreaking studies on combination therapies, including triple regimens and the use of monoclonal antibodies, highlight breakthroughs in tackling drug-resistant strains. The book also delves into cost-effectiveness analysis, particularly in the context of Chinese pediatric patients, offering critical insights for policy and practice. Additionally, it reviews the potential and challenges of experimental treatments like mesenchymal stromal cell therapy and host-targeted strategies such as CLK1 inhibitors. Each article in this collection contributes to a broader understanding of influenza treatment modalities, offering a comprehensive picture of the current landscape and future directions. This compendium is essential for healthcare professionals, researchers, and policymakers dedicated to advancing influenza therapy. Quality Research Publishing is dedicated to making knowledge more accessible to the general public by curating a topical compilation of the latest research on various subjects and providing plain language summaries. Each of the articles in this book is available individually and digitally without cost. However, we believe it is important for the contextualizing and sharing of educational and scientific work to curate this research in a way that is understandable and helpful to the average person seeking deeper knowledge of a particular subject. The research articles compiled for this book were published under a permissive Creative Commons license, are in the public domain, or have no copyright restrictions, permitting their use in this book. If you have questions about the licensing of any article, please visit qualityresearchpublishing.com.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.